Table 3 Treatment and tumor stage of colorectal cancer patients
From: Characteristics of primary signet ring cell carcinoma of colon and rectum: a case control study
SRCC (n = 18) | Non-SRCC (n = 72) | p-value | |
|---|---|---|---|
Treatment | |||
Operation | 2 (11.1) | 37 (51.4) | 0.001 |
Op + C/T | 4 (22.2) | 20 (27.8) | |
Op + C/T + Target | 10 (55.6) | 11 (15.3) | |
Op + CCRT | 2 (11.1) | 4 (5.6) | |
T | 0.002 | ||
Tis | 1 (5.6) | 0 | |
1 | 0 | 4 (5.6) | |
2 | 0 | 22 (30.5) | |
3 | 8 (44.4) | 36 (50) | |
4 | 9 (50) | 10 (13.9) | |
N | < 0.001 | ||
0 | 2 (11.1) | 44 (61.1) | |
1 | 2 (11.1) | 21 (29.2) | |
2 | 14 (77.8) | 7 (9.7) | |
M | 0.002 | ||
0 | 9 (50) | 62 (86.1) | |
1 | 9 (50) | 10 (13.9) | |
Stage | 0.001 | ||
0 | 1 (5.6) | 0 | |
1 | 0 | 23 (31.9) | |
2 | 1 (5.6) | 20 (27.8) | |
3 | 9 (50) | 18 (25) | |
4 | 7 (38.8) | 11 (15.3) | |
Follow-up duration, mean (months) | 15 | 94.5 | < 0.001 |